Giulia Caron

About Giulia Caron

Giulia Caron, With an exceptional h-index of 35 and a recent h-index of 23 (since 2020), a distinguished researcher at Università degli Studi di Torino, specializes in the field of PROTACs.

His recent articles reflect a diverse array of research interests and contributions to the field:

Link to this full text: http://hdl. handle. net/2318/1571833

Exploring the chemical space of orally bioavailable PROTACs

In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor

High-throughput and reliable assessments of the ionization constant of monoprotic organic acids through an arginine based mixed mode HPLC

Conformational sampling deciphers the chameleonic properties of a VHL-based degrader

Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

The Quest for Oral PROTAC drugs: Evaluating the Weaknesses of the Screening Pipeline

Giulia Caron Information

University

Position

___

Citations(all)

3541

Citations(since 2020)

1525

Cited By

2421

hIndex(all)

35

hIndex(since 2020)

23

i10Index(all)

79

i10Index(since 2020)

42

Email

University Profile Page

Google Scholar

Giulia Caron Skills & Research Interests

PROTACs

Top articles of Giulia Caron

Title

Journal

Author(s)

Publication Date

Link to this full text: http://hdl. handle. net/2318/1571833

Aránzazu Portillo

Rita De Sousa

Sonia Santibáñez

Ana Duarte

Sophie Edouard

...

2018/12/18

Exploring the chemical space of orally bioavailable PROTACs

Giulia Apprato

Vasanthanathan Poongavanam

Diego Garcia Jimenez

Yoseph Atilaw

Mate Erdelyi

...

2024/2/14

In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor

Molecules

Giulia Apprato

Giulia D’Agostini

Paolo Rossetti

Giuseppe Ermondi

Giulia Caron

2023/1/26

High-throughput and reliable assessments of the ionization constant of monoprotic organic acids through an arginine based mixed mode HPLC

Journal of Pharmaceutical and Biomedical Analysis

Giacomo Russo

Ardiana Kajtazi

Maura Vallaro

Pieter Surmont

Giuseppe Ermondi

...

2023/10/25

Conformational sampling deciphers the chameleonic properties of a VHL-based degrader

Pharmaceutics

Giuseppe Ermondi

Diego Garcia Jimenez

Matteo Rossi Sebastiano

Jan Kihlberg

Giulia Caron

2023/1/12

Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs

Journal of Medicinal Chemistry

Diego Garcia Jimenez

Maura Vallaro

Matteo Rossi Sebastiano

Giulia Apprato

Giulia D’Agostini

...

2023/7/25

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Christa E Müller

Finn K Hansen

Michael Gütschow

Craig W Lindsley

Dennis Liotta

2021/9/30

The Quest for Oral PROTAC drugs: Evaluating the Weaknesses of the Screening Pipeline

ACS Medicinal Chemistry Letters

Giulia Apprato

Giuseppe Ermondi

Giulia Caron

2023/7/3

Ionization and lipophilicity in nonpolar media mimicking the cell membrane interior

Bioorganic & Medicinal Chemistry

Maura Vallaro

Giuseppe Ermondi

Jaan Saame

Ivo Leito

Giulia Caron

2023/3/1

DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation Complexes

ACS Medicinal Chemistry Letters

Paolo Rossetti

Giulia Apprato

Giulia Caron

Giuseppe Ermondi

Matteo Rossi Sebastiano

2023/12/13

Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype

The American Journal of Human Genetics

Susan M Hiatt

Slavica Trajkova

Matteo Rossi Sebastiano

E Christopher Partridge

Fatima E Abidi

...

2023/2/2

Rhein to impart antimetastatic features to Pt (IV) complexes and to target brain

Elisabetta Gabano

Marzia Gariboldi

Giuseppe Ermondi

Giulia Caron

Mauro Ravera

2023/11/1

Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt (IV) complexes to obtain antiproliferative agents against human glioblastoma cells

Dalton Transactions

Elisabetta Gabano

Marzia Bruna Gariboldi

Giulia Caron

Giuseppe Ermondi

Emanuela Marras

...

2022

Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to BRo5

Journal of Medicinal Chemistry

Matteo Rossi Sebastiano

Diego Garcia Jimenez

Maura Vallaro

Giulia Caron

Giuseppe Ermondi

2022/9/12

Dall’intelligenza artificiale nuove prospettive per la ricerca sulle malattie rare

POLICY AND PROCUREMENT IN HEALTHCARE

Matteo ROSSI SEBASTIANO

Giuseppe Ermondi

Giulia Caron

Adriana Riccomagno

2022

AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin

Matteo Rossi Sebastiano

Giuseppe Ermondi

Shinji Hadano

Giulia Caron

2022/6/1

Designing soluble PROTACs: strategies and preliminary guidelines

Journal of Medicinal Chemistry

Diego García Jiménez

Matteo Rossi Sebastiano

Maura Vallaro

Valentina Mileo

Daniela Pizzirani

...

2022/4/25

Front cover:" Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies"(Molecular Pharmaceutics 02/2022)

MOLECULAR PHARMACEUTICS

Cosmin Butnarasu

Giulia Caron

Daniela Pacheco

Paola Petrini

Sonja Visentin

2022

Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies

Molecules

Matteo Rossi Sebastiano

Giuseppe Ermondi

Kai Sato

Asako Otomo

Shinji Hadano

...

2022/10/19

Collaborative online international learning (COIL) programme: Your career opportunities worldwide-learning from the experience and personal view of professionals in the sector

Pharmacy Education

P Otero

C Perez-Garcia

C Hurtado

F Spyrakis

G Caron

...

2022

See List of Professors in Giulia Caron University(Università degli Studi di Torino)